Con Kelleher

10.1k total citations · 3 hit papers
88 papers, 6.9k citations indexed

About

Con Kelleher is a scholar working on Rheumatology, Urology and Epidemiology. According to data from OpenAlex, Con Kelleher has authored 88 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Rheumatology, 70 papers in Urology and 49 papers in Epidemiology. Recurrent topics in Con Kelleher's work include Pelvic floor disorders treatments (73 papers), Urinary Bladder and Prostate Research (68 papers) and Urinary Tract Infections Management (49 papers). Con Kelleher is often cited by papers focused on Pelvic floor disorders treatments (73 papers), Urinary Bladder and Prostate Research (68 papers) and Urinary Tract Infections Management (49 papers). Con Kelleher collaborates with scholars based in United Kingdom, United States and Netherlands. Con Kelleher's co-authors include Ian Milsom, Zoë Kopp, Debra E. Irwin, Karin S. Coyne, L. Cardozo, Paul Abrams, Stefano Salvatore, V. Khullar, Walter Artibani and Sender Herschorn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Medicine & Science in Sports & Exercise.

In The Last Decade

Con Kelleher

87 papers receiving 6.6k citations

Hit Papers

Population-Based Survey o... 1997 2026 2006 2016 2006 1997 2008 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Con Kelleher 5.7k 5.5k 3.2k 1.4k 490 88 6.9k
Zoë Kopp 7.0k 1.2× 7.5k 1.4× 4.3k 1.3× 1.3k 0.9× 899 1.8× 82 9.0k
Sender Herschorn 3.9k 0.7× 4.5k 0.8× 2.0k 0.6× 1.0k 0.7× 788 1.6× 95 5.3k
David Staskin 3.5k 0.6× 3.6k 0.7× 2.0k 0.6× 1.2k 0.8× 281 0.6× 184 4.7k
Tamara Bavendam 2.9k 0.5× 3.1k 0.6× 1.6k 0.5× 749 0.5× 464 0.9× 109 3.9k
David Castro‐Díaz 2.3k 0.4× 2.7k 0.5× 1.2k 0.4× 790 0.6× 329 0.7× 144 3.7k
Steven A. Kaplan 3.5k 0.6× 5.4k 1.0× 1.4k 0.4× 827 0.6× 2.2k 4.5× 142 6.4k
E. Ann Gormley 2.2k 0.4× 2.0k 0.4× 859 0.3× 979 0.7× 253 0.5× 58 2.8k
Christian Temml 1.2k 0.2× 1.4k 0.3× 636 0.2× 521 0.4× 313 0.6× 37 2.7k
J. Dieleman 247 0.0× 390 0.1× 246 0.1× 333 0.2× 313 0.6× 30 2.2k
Katherine Gooch 496 0.1× 206 0.0× 403 0.1× 231 0.2× 287 0.6× 90 1.6k

Countries citing papers authored by Con Kelleher

Since Specialization
Citations

This map shows the geographic impact of Con Kelleher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Con Kelleher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Con Kelleher more than expected).

Fields of papers citing papers by Con Kelleher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Con Kelleher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Con Kelleher. The network helps show where Con Kelleher may publish in the future.

Co-authorship network of co-authors of Con Kelleher

This figure shows the co-authorship network connecting the top 25 collaborators of Con Kelleher. A scholar is included among the top collaborators of Con Kelleher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Con Kelleher. Con Kelleher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapple, Christopher R., Con Kelleher, Emad Siddiqui, et al.. (2021). Validation of the Overactive Bladder-Bladder Assessment Tool (OAB-BAT): A Potential Alternative to the Standard Bladder Diary for Monitoring OAB Outcomes. European Urology Focus. 7(5). 1176–1183. 8 indexed citations
5.
Brubaker, Linda, Elisabeth Piault, C. J. Evans, et al.. (2013). Validation study of the Self-Assessment Goal Achievement (SAGA) questionnaire for lower urinary tract symptoms. International Journal of Clinical Practice. 67(4). 342–350. 15 indexed citations
6.
Cortes, Eduardo, Arun Sahai, Michel A. Pontari, & Con Kelleher. (2012). The psychology of LUTS: ICI‐RS 2011. Neurourology and Urodynamics. 31(3). 340–343. 24 indexed citations
7.
Cortes, Eduardo, Evonne Chin-Smith, Con Kelleher, & Rachel M. Tribe. (2011). EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) SPLICE VARIANTS AND BLADDER DISTENSION. DOES A REDUCED BLADDER VOLUME PREVENT DETRUSOR MUSCLE REGENERATION?. Neurourology and Urodynamics. 30(6). 1183–1184. 1 indexed citations
8.
Kelleher, Con, Roger R. Dmochowski, Sandra Berriman, Zoë Kopp, & Martin Carlsson. (2011). Sustained improvement in patient‐reported outcomes during long‐term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open‐label extension studies. British Journal of Urology. 110(3). 392–400. 11 indexed citations
9.
Kirby, Michael, Adrian Wagg, Linda Cardozo, et al.. (2010). Overactive bladder: Is there a link to the metabolic syndrome in men?. Neurourology and Urodynamics. 29(8). 1360–1364. 55 indexed citations
10.
Bosch, J.L.H. Ruud, Con Kelleher, P.E.V. Van Kerrebroeck, & Brigitte Schurch. (2010). What treatment should we use if drugs fail for OAB; and, what really works after drugs?. Neurourology and Urodynamics. 29(4). 658–661. 9 indexed citations
11.
Khullar, Vikram, et al.. (2009). Does long-term treatment of overactive bladder result in clinically meaningful improvement in health related quality of life in real world clinical practice?. Neurourology and Urodynamics. 2 indexed citations
12.
Khullar, Vikram, et al.. (2009). Long-term use of antimuscarinic medication in the real world: Results of a community-based prospective study of patients with overactive bladder. Neurourology and Urodynamics. 1 indexed citations
13.
Kelleher, Con, et al.. (2008). A review of solifenacin in the treatment of urinary incontinence. SHILAP Revista de lepidopterología.
14.
Digesu, G. Alessandro, et al.. (2008). Bladder sensations during filling cystometry are different according to urodynamic diagnosis. Neurourology and Urodynamics. 28(3). 191–196. 19 indexed citations
15.
Sand, Peter K., Norman R. Zinner, Diane K. Newman, et al.. (2006). Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community‐based, randomized study. British Journal of Urology. 99(4). 836–844. 72 indexed citations
16.
Irwin, Debra E., Ian Milsom, Steinar Hunskaar, et al.. (2006). Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study. European Urology. 50(6). 1306–1315. 1988 indexed citations breakdown →
17.
Kirby, Michael, Walter Artibani, L. Cardozo, et al.. (2006). Overactive bladder: the importance of new guidance. International Journal of Clinical Practice. 60(10). 1263–1271. 22 indexed citations
18.
Kelleher, Con, Linda Cardozo, Christopher R. Chapple, François Haab, & Arwin Ridder. (2004). Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. British Journal of Urology. 95(1). 81–85. 94 indexed citations
19.
Kritchevsky, Stephen B., et al.. (1999). Definition and adjustment of Cesarean section rates and assessments of hospital performance. International Journal for Quality in Health Care. 11(4). 283–291. 20 indexed citations
20.
Kelleher, Con, L. Cardozo, Vikram Khullar, & Stefano Salvatore. (1997). A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. BJOG An International Journal of Obstetrics & Gynaecology. 104(9). 988–993. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026